Abstract
The RyR2 is a macromolecular complex comprising a Ca2+ channel and many accessory proteins that regulate channel activity. In animal models, the binding of intracellular calmodulin (CaM, ∼45 nM in the cytoplasm) partially inhibits calcium release in cardiomyocytes due to its ability to inhibit RyR2 channel opening. Single channel studies of RyR2 in lipid bilayers find that CaM inhibits RyR2 from animal hearts with an IC50 of 100 nM.In this study, RyR2 was isolated from healthy human donor hearts and hearts with ischemic cardiomyopathy (ICM) with ethics approval (UoN H-2009-0369; Univ Sydney #2012/2814; QUT EC28114) and incorporated into lipid bilayers. We found that RyR2 from healthy human hearts were not inhibited by CaM at concentrations up to 500 nM whereas for RyR2 from human hearts with ICM, CaM caused a reduction in open probability of 57% ± 6%. Dephosphorylating these RyR2 channels with Protein Phosphatase 1 prior to experiments abolished the effect of CaM, suggesting that increased RyR2 phosphorylation in ICM hearts mediates CaM inhibition in humans.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
